Skip to main content
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1981 May-Jun;54(3):201–207.

Causes of treatment failure and death in carcinoma of the lung.

J D Cox, R A Yesner
PMCID: PMC2595964  PMID: 6270919

Abstract

Studies of patterns of failure and causes of death have been undertaken based upon the WHO histopathologic classification. In a randomized trial of thoracic irradiation +/- chemotherapy (hydroxyurea and CCNU), patterns of failure did not seem to differ by cell type; the largest group was "death without progression." A subsequent clinical trial of thoracic irradiation +/- cranial irradiation permitted a more detailed evaluation. Patients with squamous cell carcinoma had a higher rate of local failure than distant metastasis. Those with small cell carcinoma had a lower local failure rate and a high rate of distant spread. Patients with adenocarcinoma and large cell carcinoma had the lowest local failure rate, but had a high rate of distant metastasis. In 300 consecutive patients with autopsies, 75 percent with squamous carcinoma died of complications of the thoracic tumor and only one-quarter had extrathoracic dissemination; 30 percent with small cell carcinoma died of local tumor complications and 70 percent had carcinomatosis; 40 percent of patients with adenocarcinoma and large cell carcinoma died of intrathoracic complications, and 55 percent had distant metastases. Half the patients with small cell carcinoma, large cell carcinoma, and adenocarcinoma had brain metastases at autopsy. Future clinical trials should emphasize better control of the most common sites of failure.

Full text

PDF
201

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cox J. D., Petrovich Z., Paig C., Stanley K. Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung: preliminary report of a cooperative trial. Cancer. 1978 Sep;42(3):1135–1140. doi: 10.1002/1097-0142(197809)42:3<1135::aid-cncr2820420316>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  2. Cox J. D., Stanley K., Petrovich Z., Paig C., Yesner R. Cranial irradiation in cancer of the lung of all cell types. JAMA. 1981 Feb 6;245(5):469–472. [PubMed] [Google Scholar]
  3. Cox J. D., Yesner R., Mietlowski W., Petrovich Z. Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung. Cancer. 1979 Jul;44(1):94–98. doi: 10.1002/1097-0142(197907)44:1<94::aid-cncr2820440117>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  4. Komaki R., Cox J. D., Eisert D. R. Irradiation of bronchial carcinoma--II. Pattern of spread and potential for prophylactic irradiation. Int J Radiat Oncol Biol Phys. 1977 May-Jun;2(5-6):441–446. doi: 10.1016/0360-3016(77)90155-9. [DOI] [PubMed] [Google Scholar]
  5. Petrovich Z., Mietlowski W., Ohanian M., Cox J. Clinical report of the treatment of locally advanced lung cancer. Cancer. 1977 Jul;40(1):72–77. doi: 10.1002/1097-0142(197707)40:1<72::aid-cncr2820400114>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  6. Petrovich Z., Ohanian M., Cox J. Clinical research on the treatment of locally advanced lung cancer: final report of VALG Protocol 13 Limited. Cancer. 1978 Sep;42(3):1129–1134. doi: 10.1002/1097-0142(197809)42:3<1129::aid-cncr2820420315>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES